We are live on ! Find out more
CMRA

Comera Life Sciences Holdings, Inc. Common Stock
CMRA

Delisted

CMRA was delisted on the 16th of November, 2023.

Back to rankings

11 hedge funds and large institutions have $190K invested in Comera Life Sciences Holdings, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

0.27% less ownership

Funds ownership: 2.64% → 2.36% (-0.27%)

8% less funds holding

Funds holding: 12 → 11 (-1)

70% less capital invested

Capital invested by funds: $643K → $190K (-$453K)

Holders
11
Holders Change
-1
Holders Change %
-8.33%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
+$5.37K
2
UBS Group
UBS Group
Switzerland
+$1.04K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$126
4
Wells Fargo
Wells Fargo
California
+$30

Top Sellers

Rank Fund Capital Flow
1
Osaic Holdings
Osaic Holdings
Arizona
-$1.26K
2
Morgan Stanley
Morgan Stanley
New York
-$4

CMRA Hedge Fund Activity: Q1 2023 in Review

11 of the 6,284 institutional investors tracked by Wall St. Rank reported a position in Comera Life Sciences Holdings, Inc. Common Stock (CMRA) for Q1 2023, worth a combined $190K — down 70% from $643K a quarter earlier.

Fund positioning in CMRA was balanced in Q1 2023: 0 funds opened new positions, 0 closed out, 4 added to existing stakes and 2 trimmed.

The largest buyer was Tower Research Capital (TRC), adding an estimated $5.37K. The largest seller was Osaic Holdings, cutting an estimated $1.26K.

  • 11 institutional investors held Comera Life Sciences Holdings, Inc. Common Stock (CMRA) as of Q1 2023, down from 12 in Q4 2022.
  • Funds reported $190K of Comera Life Sciences Holdings, Inc. Common Stock stock for Q1 2023, down 70% quarter-over-quarter.
  • 0 funds opened new Comera Life Sciences Holdings, Inc. Common Stock positions in Q1 2023 and 0 closed out.
  • The largest Comera Life Sciences Holdings, Inc. Common Stock buyer in Q1 2023 was Tower Research Capital (TRC), an estimated $5.37K added.
  • The largest Comera Life Sciences Holdings, Inc. Common Stock seller in Q1 2023 was Osaic Holdings, an estimated $1.26K sold.

Based on aggregated 13F filings for Q1 2023.